Drugs / Olfactory Ensheathing Cell
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07596563 Comparator | May 2026 → May 2031 expected | spinal cord injury | Dr Brent McMonagle | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Olfactory Ensheathing Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07596563 ↗ |
| Modality | Cell therapy | “combined cell transplantation and intensive rehabilitation intervention” NCT07596563 ↗ |
| Route | Other | “the nerve bridges to be placed into the injury site” NCT07596563 ↗ |